Abstract:Nanoparticles (NPs) that are ∼100 nm in diameter can potentially cause toxicity in the central nervous system (CNS). Although NPs exhibit positive aspects, these molecules primarily exert negative or harmful effects. Thus, the beneficial and harmful effects should be compared. The prevalence of neurodegenerative diseases, such as Alzheimer disease, Parkinson disease, and some brain tumors, has increased. However, the major cause of these diseases remains unknown. NPs have been considered as one of the major potential causes of these diseases, penetrating the human body via different pathways. This review summarizes various pathways for NP-induced neurotoxicity, suggesting the development of strategies for nanoneuroprotection using in silico and biological methods. Studies of oxidative stress associated with gene expression analyses provide efficient information for understanding neuroinflammation and neurodegeneration associated with NPs. The brain is a sensitive and fragile organ, and evolution has developed mechanisms to protect it from injury; however, this protection also hinders the methods used for therapeutic purposes. Thus, brain and CNS-related diseases that are the cause of disability and disorder are the most difficult to treat. There are many obstacles to drug delivery in the CNS, such as the blood brain barrier and blood tumor barrier. Considering these barriers, we have reviewed the strategies available to map NPs using biological techniques. The surface adsorption energy of NPs is the basic force driving NP gathering, protein corona formation, and many other interactions of NPs within biological systems. These interactions can be described using an approach named the biological surface adsorption index. A quantitative structural activity relationship study helps to understand different protein-protein or protein-ligand interactions. Moreover, equilibrium between cerebrovascular permeability is required when a drug is transferred via the circulatory system for the therapy of neurodegenerative diseases. Various drug delivery approaches, such as chemical drug delivery and carrier-mediated drug delivery, have been established to avoid different barriers inhibiting CNS penetration by therapeutic substances. Developing an improved understanding of drug receptors and the sites of drug action, together with advances in medicinal chemistry, will make it possible to design drugs with greatly enhanced activity and selectivity; this may result in a significant increase in the therapeutic index.

Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders

Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders

Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects.

Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases

Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases

Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer’s and Parkinson’s Disease

Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development.

Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer'S and Parkinson'S Disease

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective

Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective

Nanoparticles, Neurotoxicity and Neurodegenerative Diseases

Nanomedicine: A Promising Way to Manage Alzheimer’s Disease

An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy.

Natural products in the management of neurodegenerative diseases

Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment

Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection

Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management

Nanotechnological advancement for the treatment of neurodegenerative disorders

Progressing neurobiological strategies against proteostasis failure: Challenges in neurodegeneration

Nanoneurotoxicity to nanoneuroprotection using biological and computational approaches.

A Nanotechnological Approach to the Management of Alzheimer Disease and Type 2 Diabetes